This site uses cookies and by using the site you are consenting to this. Find out what cookies are, why we use them and how to manage your settings in our cookie policy.

Changing your cookie settings

All browsers provide tools that allow you to control how they handle cookies: accept, reject or delete them. These settings are normally accessed via the 'preferences' or 'options' menu of the browser you are using. Read more...

C4X Discovery

A new dimension in drug discovery

Chairman: Clive Dix, PhD

Clive has over 20 years' experience in the pharmaceutical and biotechnology industries. He was CEO and co-founder of PowderMed Limited, which was sold to Pfizer Inc. in 2006. Following post-doctoral roles and a period at Ciba-Geigy AG (now Novartis AG), Clive joined GlaxoWellcome plc where he became UK Research Director.

Other previous roles include: Senior Vice President of research and development at PowderJect Pharmaceuticals plc, Chairman of the UK BioIndustry Association, Chairman of Crescendo Biologicals Limited and Chairman of Auralis Limited (acquired by ViroPharma Inc).

Clive is currently CEO of Convergence Pharmaceuticals Limited and Chairman of Touchlight Genetics Limited.


Copyright © 2015 C4X Discovery Holdings plc.
Registered in England and Wales with registered number 09134041.
Registered office: Unit 310 Ducie House, Ducie Street, Manchester, M1 2JW, United Kingdom.

Medilink Business Awards 2013 - Innovation